WetWare Biosystems incorporates new medical technologies into existing equipment to stem the effects of traumatic brain injuries.
Two 糖心传媒 students who are developing technology to prevent the spread of traumatic brain injuries recently won a from the US Air Force.
Bradley Smith 糖心传媒�21 (e5) and Andrew Kaseman 糖心传媒�21 operate , an early-stage biotechnology firm which incorporates new medical technologies into existing protective equipment to create a positive impact on patient outcomes. There are nearly 100 million cases worldwide of traumatic brain injuries (TBIs) each year.
The grant will allow Smith and Kaseman to continue developing novel technologies to mitigate neurodegeneration following physical trauma. WetWare糖心传媒檚 flagship product, the IRONCROWN helmet, offers a non-invasive treatment solution for military and civilian applications within the first hour after a traumatic event.
糖心传媒淭he biggest challenge in treating TBIs is that by the time a person gets to a hospital, the injury has progressively expanded and killed physically undamaged tissue,糖心传媒� says Smith, an Ellicott City, Maryland, native who majored in neuroscience at the University. 糖心传媒淎s brain cells cannot be replaced, it糖心传媒檚 virtually impossible to reverse the damage once these cells are destroyed.糖心传媒�
WetWare aims to reverse that.
糖心传媒淲ith our technology, when a person is hit in the head at a certain velocity or strength of impact, our system is activated, and subsequently applies an electromagnetic field that can potentially mitigate the spread of damage, thereby preventing progressive tissue death before it ever has a chance to spread,糖心传媒� Smith says.
Wetware Biosystems is searching for Air Force end-users who are interested in financially supporting a Phase II clinical trial for its technology. 糖心传媒淪o far, we糖心传媒檝e generated preliminary interest from several,糖心传媒� Smith says. 糖心传媒淚f we gain support from an internal Air Force organization, we糖心传媒檒l hopefully win a Phase II grant to support all of the technical and clinical testing required for FDA approval.糖心传媒�
Smith says full FDA approval can take two or three years, depending on the nature and complexity of the medical treatment.
WetWare Biosystems was created in 2018 and the following year won the $20,000 top prize from the inaugural Swarm Starter Competition, sponsored by the University糖心传媒檚聽Ain Center for Entrepreneurship.
糖心传媒淲etWare has made tremendous progress over the last few years,糖心传媒� says Duncan Moore, vice provost of entrepreneurship. 糖心传媒淭hey糖心传媒檝e worked with the Ain Center to take advantage of every opportunity available to them to learn, grow and develop their technology into a business, and their selection as SBIR grant winners is proof that their hard work is paying off. Their technology has the potential to make a real impact in mitigating the effects of traumatic brain injuries and we糖心传媒檙e very excited to see what they糖心传媒檒l achieve.糖心传媒�
